Self-Glucose Measurement Devices
- Blood Glucose Meter
- Blood Glucose Testing Strips
- Lancets, Others
- Continuous Glucose Measurement Devices
Blood Glucose Measurement Market size was valued at USD 15.82 billion in 2023 and is projected to grow at a CAGR of 10.1% from 2024-2030. Diabetes mellitus is a group of diseases that affects blood sugar (glucose) levels in the body. Glucose is very important for health as it's a vital energy source of the cells which is helpful to build the muscles and tissues. Blood Glucose Measurement Market is one of the sources to fuel brain activities. Diabetes is characterized by increased levels of glucose in the blood. Blood glucose measuring devices help the patients and healthcare professionals measure the glucose levels in the blood. The blood glucose monitoring devices market is driven by the high incidence of diabetes worldwide. According to the World Health Organisation (WHO), the prevalence of diabetes among adults about 18 years, old rose from 4.7% to 8.5% from 2012 to 2014 and diabetes is the 7th leading cause of death. In addition to these factors, the rise in advancements in technology like the evolution of continuous glucose monitoring devices are boosting the growth of the blood glucose monitoring devices market. Moreover, the rise in demand for portable self-glucose measuring devices, the rise in investments and activities in R&D, and funds from the government in preventing and treating diabetes are boosting the growth of blood glucose measurement devices. Frequent product recalls of glucose testing strips owing to the manufactural defects and supply of test strips which are, less differentiated products among the self-blood glucose monitors are some of the factors that are hampering the growth of blood glucose measurement devices. Due to limited facilities of reimbursement and availability of alternative treatments which include cell-based assays, identification of biomarkers and artificial pancreas and high costs of the devices are the few threats for the growth of the market.
Global Blood Glucose Measurement Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
10.1%
Largest Market
Europe
Fastest Growing Market
North America
Blood Glucose Measurement Market Dynamics
Market players are investing heavily to innovate products in order to maintain their position in the market, acquisitions and collaborations are the key strategies are used by the market players in order to increase the market share of the companies. For example, in 2017, Abbott Laboratories entered an agreement with Bigfoot Biomedical to commercialize and develop the diabetes management systems and also a Switzerland based company Ascensia Diabetes Care entered partnership with Medtronic to develop and market the diabetes management solutions.
North-America Got Significant Share
Blood Glucose Measurement Market Regional Analysis
Geographically blood glucose measurement market is divided into five key regions Asia- Pacific, North America, Middle East & Africa, Europe and Latin America. North America expected to be the leader in blood glucose measurement market and expected to have a significant growth rate during the forecast period. Europe region is also expected to show a notable rate of growth due to the changes in lifestyle and rise in adaption of home care diagnosis. Asia-Pacific region due to growing awareness about diabetes consequences like cardiac related issues are contributing the regions to show a significant growth. Initiatives taken by the government and non-government organizations in order to spread the awareness about the early diagnosis of diabetes, changes in lifestyle, large pool of patients are expected to drive the blood glucose measurement market growth.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Blood Glucose Measurement Market Segmentation
By Product Type
By End User
- Hospitals
- Diagnostic Centres
- Home Settings
- Others
Frequently Asked Questions
The blood glucose measurement market size was valued at USD 15.82 billion in 2023
The blood glucose measurement market's key players are: Abbott Laboratories (U.S.) ARKRAY (Japan) Medtronic (U.S.) Bayer AG (Germany) Dexcom, Inc. (U.S.) Hoffmann-La Roche Ltd (Switzerland) Johnson and Johnson Services Inc. (U.S.) Terumo Medical Corporation (U.S.)
The blood glucose measurement market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary
2. Global Blood Glucose Measurement Devices Market Introduction
2.1. Global Blood Glucose Measurement Devices Market Taxonomy
2.2. Global Blood Glucose Measurement Devices Market Definitions
2.2.1. Device Type
2.2.2. End User
3. Global Blood Glucose Measurement Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Blood Glucose Measurement Devices Market Dynamic Factors - Impact Analysis
4. Global Blood Glucose Measurement Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Blood Glucose Measurement Devices Market, By Device Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Self-Glucose Measurement Devices
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Continuous Glucose Measurement Devices
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Blood Glucose Measurement Devices Market, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. Hospitals 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Diagnostic Centers
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Home Settings
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Blood Glucose Measurement Devices Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Region, 2024 - 2030
8. North America Blood Glucose Measurement Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Self-Glucose Measurement Devices
8.1.1.1. Blood Glucose Meter
8.1.1.2. Blood Glucose Testing Strips
8.1.1.3. Lancets
8.1.1.4. Others
8.1.2. Continuous Glucose Measurement Devices
8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Hospitals
8.2.2. Diagnostic Centres
8.2.3. Home Settings
8.2.4. Others
8.3. Country Analysis 2018 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2024 - 2030
8.5. North America Blood Glucose Measurement Devices Market Dynamics Trends
9. Europe Blood Glucose Measurement Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Self-Glucose Measurement Devices
9.1.1.1. Blood Glucose Meter
9.1.1.2. Blood Glucose Testing Strips
9.1.1.3. Lancets
9.1.1.4. Others
9.1.2. Continuous Glucose Measurement Devices
9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Hospitals
9.2.2. Diagnostic Centres
9.2.3. Home Settings
9.2.4. Others
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2024 - 2030
9.5. Europe Blood Glucose Measurement Devices Market Dynamics Trends
10. Asia-Pacific Blood Glucose Measurement Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Self-Glucose Measurement Devices
10.1.1.1. Blood Glucose Meter
10.1.1.2. Blood Glucose Testing Strips
10.1.1.3. Lancets
10.1.1.4. Others
10.1.2. Continuous Glucose Measurement Devices
10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Hospitals
10.2.2. Diagnostic Centres
10.2.3. Home Settings
10.2.4. Others
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2024 - 2030
10.5. Asia-Pacific Blood Glucose Measurement Devices Market Dynamics – Trends
11. Latin America Blood Glucose Measurement Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Self-Glucose Measurement Devices
11.1.1.1. Blood Glucose Meter
11.1.1.2. Blood Glucose Testing Strips
11.1.1.3. Lancets
11.1.1.4. Others
11.1.2. Continuous Glucose Measurement Devices
11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Hospitals
11.2.2. Diagnostic Centres
11.2.3. Home Settings
11.2.4. Others
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2024 - 2030
11.5. Latin America Blood Glucose Measurement Devices Market Dynamics Trends
12. Middle East and Africa Blood Glucose Measurement Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Self-Glucose Measurement Devices
12.1.1.1. Blood Glucose Meter
12.1.1.2. Blood Glucose Testing Strips
12.1.1.3. Lancets
12.1.1.4. Others
12.1.2. Continuous Glucose Measurement Devices
12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Hospitals
12.2.2. Diagnostic Centres
12.2.3. Home Settings
12.2.4. Others
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2024 - 2030
12.5. MEA Blood Glucose Measurement Devices Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Nipro Diagnostics, Inc. (U.S.)
13.2.2. Abbott Laboratories (U.S.)
13.2.3. ARKRAY (Japan)
13.2.4. Medtronic (U.S.)
13.2.5. Bayer AG (Germany)
13.2.6. Dexcom, Inc. (U.S.)
13.2.7. F. Hoffmann-La Roche Ltd (Switzerland)
13.2.8. Johnson and Johnson Services Inc. (U.S.)
13.2.9. Terumo Medical Corporation (U.S.)
14. Research Methodology
15. Key Assumptions and Acronyms
- Abbott Laboratories (U.S.)
- ARKRAY (Japan)
- Medtronic (U.S.)
- Bayer AG (Germany)
- Dexcom, Inc. (U.S.)
- Hoffmann-La Roche Ltd (Switzerland)
- Johnson and Johnson Services Inc. (U.S.)
- Terumo Medical Corporation (U.S.)